Latest from What Investment

'Extreme complacency' means that capital preservation is key for investors this year: Stout

'Extreme complacency' means that capital preservation is key for investors this year: Stout

News | Funds | 24 Jul 2014

Bruce Stout, manager of the £1.4 billion Murray International (LON:MYI) investment trust, continues to hold a robustly bearish view of the global economy, warning investors that in the current market ‘capital preservation is key'.

Schroders: Long-term confidence required to invest in new technology companies is 'not reasonable'

Schroders: Long-term confidence required to invest in new technology companies is 'not reasonable'

News | Markets | 23 Jul 2014

It is not reasonable to expect investors to make the leap of faith required in order to make an investment in a new technology company, according to James Gautrey, telecoms and technology analyst at Schroders.

Mike Prentis: The best UK smaller companies for private investors today

Mike Prentis: The best UK smaller companies for private investors today

News | Shares & trading | 23 Jul 2014

Mike Prentis, high performing manager of the BlackRock Smaller Companies (LON:BRSC) investment trust, which has returned 411 per cent in the past ten years compared to 237 per cent for the AIC UK Smaller Companies sector, has outlined for What Investment the smaller company stocks he feel offer the best value for UK private investors right now. 

Gervais Williams: Why I am sticking with Quindell, despite the criticisms

Gervais Williams: Why I am sticking with Quindell, despite the criticisms

Opinion | Comment & Analysis | 23 Jul 2014

Gervais Williams, the veteran small-cap fund manager, has outlined for What Investment his reasons for continuing to own insurance software business Quindell (LON:QPP), despite market sentiment dramatically shifting against the company. 

M&G: BP is a better investment than Shell right now

M&G: BP is a better investment than Shell right now

News | Shares & trading | 22 Jul 2014

Mike Felton, manager of the £720 million M&G UK Growth fund, believes that investors should prefer BP (LON:BP) to Shell (LON:RDSB) at the present time.

New Burford Capital retail bond 'too risky' for the typical private investor

New Burford Capital retail bond 'too risky' for the typical private investor

News | Funds | 22 Jul 2014

Bryn Jones, head of fixed income at Rathbone Unit Trust Management, has told What Investment that the new retail bond issued by litigation financier Burford Capital is only suitable for investors with a higher than average risk profile.

Hargreaves Lansdown: Tesco shares a 'sell', despite CEO change

Hargreaves Lansdown: Tesco shares a 'sell', despite CEO change

News | Shares & trading | 21 Jul 2014

The announcement this morning that Tesco (LON:TSCO) is to change its chief executive should not immediately change investors' view of the stock, which remains a ‘sell’ according to Keith Bowman, equity analyst at Hargreaves Lansdown.

Shock for investors as Harry Nimmo's UK Smaller Companies fund named on 'Spot the Dog' list

Shock for investors as Harry Nimmo's UK Smaller Companies fund named on 'Spot the Dog' list

News | Funds | 19 Jul 2014

Harry Nimmo’s Standard Life Investments UK Smaller Companies fund, long a beacon for smaller companies investors, has been named on Bestinvest’s 'Spot the Dog' list of underperforming funds.

Richard Buxton: Barclays shares are 'undervalued by any long-term measure'

Richard Buxton: Barclays shares are 'undervalued by any long-term measure'

News | Funds | 17 Jul 2014

Richard Buxton, manager of the £1.4 billion Old Mutual UK Alpha fund, has told What Investment that he intends to continue to add to his fund’s holdings in banking giant Barclays (LON:BARC), despite the negativity that surrounds the company at present. 

The two IPOs Neil Woodford has bought this year

The two IPOs Neil Woodford has bought this year

News | Funds | 16 Jul 2014

High profile fund manager Neil Woodford, who raised £1.6 billion in just 13 days from investors in his new CF Woodford Equity Income fund, has bought shares in just two of the companies that have come to the market via initial public offerings (IPOs) this year.

Income investors likely to find VCTs 'very attractive'

Income investors likely to find VCTs 'very attractive'

News | Funds | 16 Jul 2014

Venture capital trusts (VCTs) are likely to hold particular attractions for investors searching for income over the coming year, according to Jason Hollands, managing director at Bestinvest.

Hargreaves Lansdown: Higher than expected inflation should not mean early UK interest rate rise

Hargreaves Lansdown: Higher than expected inflation should not mean early UK interest rate rise

News | Banking & savings | 15 Jul 2014

Despite annual UK consumer price inflation (CPI) leaping to 1.9 per cent in June, compared to 1.5 per cent the previous month, investors should not be spooked into thinking that a rise in interest rates is now nearer at hand according to Ben Brettell, senior economist at Hargreaves Lansdown.

JP Morgan: The best five stocks for Eurozone investors right now

JP Morgan: The best five stocks for Eurozone investors right now

News | Shares & trading | 15 Jul 2014

John Baker, the high performing manager of the JP Morgan Europe Dynamic Ex UK fund, has outlined the five stocks that he believes represent best value in the Eurozone at present. 

Schroders: India and South Africa are the best value emerging markets

Schroders: India and South Africa are the best value emerging markets

News | Markets | 15 Jul 2014

Keith Wade, chief economist at Schroders, believes that while the case for investing in emerging markets is ‘compelling’, those looking at the asset class need to be very selective at present. 

Giant M&G Recovery fund continues to shed cash as poor performance persists

Giant M&G Recovery fund continues to shed cash as poor performance persists

News | Funds | 14 Jul 2014

The M&G Recovery fund, which since 1969 has been a beacon for those seeking to invest in undervalued stocks in the UK, continues to shed cash as the fund continues to deeply underperform its sector. 

Innovation in biotech is the best we’ve ever seen it: Biotech Growth manager

Innovation in biotech is the best we’ve ever seen it: Biotech Growth manager

News | Funds | 11 Jul 2014

Geoffrey Hsu, general partner at US-based Orbimed which manages the Biotech Growth investment trust (LON:BIOG), has said that the potential of biotech companies to launch multi-billion dollar drugs and grow their earnings is ‘much more substantial’ now than in previous years.